Order Article Reprints

Menzel A, Samouda H, Dohet F, Loap S, Ellulu MS, Bohn T. Reply to Mrakic-Sposta et al. Comment on “Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414”. Antioxidants. 2021; 10(6):865. https://doi.org/10.3390/antiox10060865

Menzel, Alain, Hanen Samouda, Francois Dohet, Suva Loap, Mohammed S. Ellulu, and Torsten Bohn. 2021. "Reply to Mrakic-Sposta et al. Comment on “Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414”" Antioxidants 10, no. 6: 865. https://doi.org/10.3390/antiox10060865

Menzel, A., Samouda, H., Dohet, F., Loap, S., Ellulu, M. S., & Bohn, T. (2021). Reply to Mrakic-Sposta et al. Comment on “Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414”. Antioxidants, 10(6), 865. https://doi.org/10.3390/antiox10060865